{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:43:29Z","timestamp":1780983809303,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0371"],"award-info":[{"award-number":["P3-0371"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08360-x","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:01:53Z","timestamp":1723500113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms of treatment effects using allogeneic, umbilical cord-derived mesenchymal stromal stem cells (MSCs) in knee osteoarthritis: a pharmacological clinical study protocol"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1908-4254","authenticated-orcid":false,"given":"Urban","family":"\u0160vajger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matic","family":"Kolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Kobold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Drobni\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"6","key":"8360_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.knee.2010.08.010","volume":"18","author":"CB Chang","year":"2011","unstructured":"Chang CB, et al. The radiographic predictors of symptom severity in advanced knee osteoarthritis with varus deformity. Knee. 2011;18(6):456\u201360.","journal-title":"Knee"},{"issue":"8","key":"8360_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9","volume":"41","author":"DT Felson","year":"1998","unstructured":"Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343\u201355.","journal-title":"Arthritis Rheum"},{"issue":"24","key":"8360_CR3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1001\/jama.2021.6024","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant K, Loeser RF. Review of hip and knee osteoarthritis-reply. JAMA. 2021;325(24):2505.","journal-title":"JAMA"},{"issue":"9","key":"8360_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8360_CR5","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712.","journal-title":"Cell Prolif"},{"issue":"17","key":"8360_CR6","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.3390\/ijms231710023","volume":"23","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 2022;23(17):10023.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"8360_CR7","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","volume":"74","author":"N Li","year":"2017","unstructured":"Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74(13):2345\u201360.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"8360_CR8","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838\u201343.","journal-title":"Blood"},{"issue":"3","key":"8360_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse WT, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75(3):389\u201397.","journal-title":"Transplantation"},{"key":"8360_CR10","first-page":"39","volume":"380","author":"MG Roncarolo","year":"2014","unstructured":"Roncarolo MG, et al. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol. 2014;380:39\u201368.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"8360_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson I, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76(8):1208\u201313.","journal-title":"Transplantation"},{"issue":"3\u20134","key":"8360_CR12","first-page":"469","volume":"41","author":"D Angoulvant","year":"2004","unstructured":"Angoulvant D, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology. 2004;41(3\u20134):469\u201376.","journal-title":"Biorheology"},{"issue":"3","key":"8360_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/BOR.0000000000000162","volume":"27","author":"CJ Malemud","year":"2015","unstructured":"Malemud CJ. Biologic basis of osteoarthritis: state of the evidence. Curr Opin Rheumatol. 2015;27(3):289\u201394.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"8360_CR14","doi-asserted-by":"publisher","first-page":"FSO228","DOI":"10.4155\/fsoa-2017-0055","volume":"3","author":"DC Ilas","year":"2017","unstructured":"Ilas DC, et al. Targeting subchondral bone mesenchymal stem cell activities for intrinsic joint repair in osteoarthritis. Future Sci OA. 2017;3(4):FSO228.","journal-title":"Future Sci OA"},{"issue":"12","key":"8360_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrrheum.2017.182","volume":"13","author":"D McGonagle","year":"2017","unstructured":"McGonagle D, Baboolal TG, Jones E. Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis. Nat Rev Rheumatol. 2017;13(12):719\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"8360_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/genes8100270","volume":"8","author":"D Hudetz","year":"2017","unstructured":"Hudetz D, et al. The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel). 2017;8(10):270.","journal-title":"Genes (Basel)"},{"issue":"3","key":"8360_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3325\/cmj.2019.60.227","volume":"60","author":"D Hudetz","year":"2019","unstructured":"Hudetz D, et al. Early results of intra-articular micro-fragmented lipoaspirate treatment in patients with late stages knee osteoarthritis: a prospective study. Croat Med J. 2019;60(3):227\u201336.","journal-title":"Croat Med J"},{"issue":"12","key":"8360_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/genes10121051","volume":"10","author":"I Boric","year":"2019","unstructured":"Boric I, et al. A 24-month follow-up study of the effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel). 2019;10(12):1051.","journal-title":"Genes (Basel)"},{"issue":"10075","key":"8360_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352.","journal-title":"Lancet"},{"issue":"23","key":"8360_CR20","doi-asserted-by":"publisher","first-page":"e014240","DOI":"10.1161\/JAHA.119.014240","volume":"8","author":"C Caraballo","year":"2019","unstructured":"Caraballo C, et al. Clinical implications of the New York Heart Association classification. J Am Heart Assoc. 2019;8(23):e014240.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"8360_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(83)90088-X","volume":"16","author":"AM Carlsson","year":"1983","unstructured":"Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87\u2013101.","journal-title":"Pain"},{"key":"8360_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1477-7525-1-64","volume":"1","author":"EM Roos","year":"2003","unstructured":"Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"8360_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G. EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"1_suppl","key":"8360_CR24","doi-asserted-by":"publisher","first-page":"82S","DOI":"10.1177\/1947603520942941","volume":"13","author":"A Boffa","year":"2021","unstructured":"Boffa A, et al. Synovial fluid biomarkers in knee osteoarthritis: a systematic review and quantitative evaluation using BIPEDs criteria. Cartilage. 2021;13(1_suppl):82S-103S.","journal-title":"Cartilage"},{"issue":"3","key":"8360_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00223-020-00701-7","volume":"109","author":"VB Kraus","year":"2021","unstructured":"Kraus VB, Karsdal MA. Osteoarthritis: current molecular biomarkers and the way forward. Calcif Tissue Int. 2021;109(3):329\u201338.","journal-title":"Calcif Tissue Int"},{"issue":"1_suppl","key":"8360_CR26","doi-asserted-by":"publisher","first-page":"1511S","DOI":"10.1177\/1947603520941239","volume":"13","author":"JG Convill","year":"2021","unstructured":"Convill JG, et al. Clinically relevant molecular biomarkers for use in human knee osteoarthritis: a systematic review. Cartilage. 2021;13(1_suppl):1511S-1531S.","journal-title":"Cartilage"},{"issue":"3","key":"8360_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/ph14030205","volume":"14","author":"D Primorac","year":"2021","unstructured":"Primorac D, et al. Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies\u2019 guidelines. Pharmaceuticals (Basel). 2021;14(3):205.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"8360_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/bmc-2019-0014","volume":"10","author":"A Munjal","year":"2019","unstructured":"Munjal A, et al. Advances in molecular biomarker for early diagnosis of osteoarthritis. Biomol Concepts. 2019;10(1):111\u20139.","journal-title":"Biomol Concepts"},{"issue":"11","key":"8360_CR29","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/annrheumdis-2013-203726","volume":"72","author":"M Lotz","year":"2013","unstructured":"Lotz M, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013;72(11):1756\u201363.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8360_CR30","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1177\/002215549704501104","volume":"45","author":"A Oganesian","year":"1997","unstructured":"Oganesian A, Zhu Y, Sandell LJ. Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem. 1997;45(11):1469\u201380.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"8360_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","volume":"76","author":"VB Kraus","year":"2017","unstructured":"Kraus VB, et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium. Ann Rheum Dis. 2017;76(1):186\u201395.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8360_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40634-014-0008-7","volume":"1","author":"PJ Roughley","year":"2014","unstructured":"Roughley PJ, Mort JS. The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop. 2014;1(1):8.","journal-title":"J Exp Orthop"},{"issue":"1","key":"8360_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13075-017-1471-1","volume":"19","author":"Y Sobue","year":"2017","unstructured":"Sobue Y, et al. Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study. Arthritis Res Ther. 2017;19(1):265.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8360_CR34","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/ar2735","volume":"11","author":"S Larsson","year":"2009","unstructured":"Larsson S, Lohmander LS, Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther. 2009;11(3):R92.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8360_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5606\/ArchRheumatol.2017.6220","volume":"32","author":"RD Arellano","year":"2017","unstructured":"Arellano RD, et al. Cartilage oligomeric matrix protein levels in synovial fluid in patients with primary knee osteoarthritis and healthy controls: a preliminary comparative analysis with serum cartilage oligomeric matrix protein. Arch Rheumatol. 2017;32(3):189\u201396.","journal-title":"Arch Rheumatol"},{"issue":"6","key":"8360_CR36","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.knee.2017.04.018","volume":"24","author":"Q Wu","year":"2017","unstructured":"Wu Q, Sun X, Du L. Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: a cross-sectional study. Knee. 2017;24(6):1369\u201373.","journal-title":"Knee"},{"issue":"5","key":"8360_CR37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00296-017-3887-y","volume":"38","author":"T Georgiev","year":"2018","unstructured":"Georgiev T, et al. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study. Rheumatol Int. 2018;38(5):821\u201330.","journal-title":"Rheumatol Int"},{"issue":"1","key":"8360_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.joca.2006.06.005","volume":"15","author":"TA Schmidt","year":"2007","unstructured":"Schmidt TA, Sah RL. Effect of synovial fluid on boundary lubrication of articular cartilage. Osteoarthritis Cartilage. 2007;15(1):35\u201347.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"8360_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.joca.2014.09.017","volume":"23","author":"PA Band","year":"2015","unstructured":"Band PA, et al. Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis Cartilage. 2015;23(1):70\u20136.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"8360_CR40","first-page":"885","volume":"15","author":"X Li","year":"2018","unstructured":"Li X, et al. Expression of tissue inhibitor of metalloproteinases-1 and B-cell lymphoma-2 in the synovial membrane in patients with knee osteoarthritis. Exp Ther Med. 2018;15(1):885\u20139.","journal-title":"Exp Ther Med"},{"issue":"3","key":"8360_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.joca.2018.12.002","volume":"27","author":"F Saberi Hosnijeh","year":"2019","unstructured":"Saberi Hosnijeh F, Bierma-Zeinstra SM, Bay-Jensen AC. Osteoarthritis year in review 2018: biomarkers (biochemical markers). Osteoarthritis Cartilage. 2019;27(3):412\u201323.","journal-title":"Osteoarthritis Cartilage"},{"key":"8360_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jor.2023.02.014","volume":"38","author":"S Singh","year":"2023","unstructured":"Singh S, Jindal D, Khanna R. Can serum MMP-3 diagnose early knee osteoarthritis? J Orthop. 2023;38:42\u20136.","journal-title":"J Orthop"},{"issue":"2","key":"8360_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.joca.2020.10.009","volume":"29","author":"M Bollmann","year":"2021","unstructured":"Bollmann M, et al. MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity. Osteoarthritis Cartilage. 2021;29(2):280\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"8360_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.joca.2007.09.014","volume":"16","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, et al. Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2008;16(4):526\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"8360_CR45","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","volume":"20","author":"BJ de Lange-Brokaar","year":"2012","unstructured":"de Lange-Brokaar BJ, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012;20(12):1484\u201399.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"8360_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11926-017-0672-6","volume":"19","author":"E Kalaitzoglou","year":"2017","unstructured":"Kalaitzoglou E, Griffin TM, Humphrey MB. Innate immune responses and osteoarthritis. Curr Rheumatol Rep. 2017;19(8):45.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"8360_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/jor.25157","volume":"40","author":"Y Ohashi","year":"2022","unstructured":"Ohashi Y, et al. Correlation between CD163 expression and resting pain in patients with hip osteoarthritis: possible contribution of CD163+ monocytes\/macrophages to pain pathogenesis. J Orthop Res. 2022;40(6):1365\u201374.","journal-title":"J Orthop Res"},{"issue":"4","key":"8360_CR48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/art.39006","volume":"67","author":"HN Daghestani","year":"2015","unstructured":"Daghestani HN, Pieper CF, Kraus VB. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol. 2015;67(4):956\u201365.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"8360_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-0035-1549022","volume":"29","author":"F Monibi","year":"2016","unstructured":"Monibi F, et al. Identification of synovial fluid biomarkers for knee osteoarthritis and correlation with radiographic assessment. J Knee Surg. 2016;29(3):242\u20137.","journal-title":"J Knee Surg"},{"issue":"9","key":"8360_CR50","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/art.39677","volume":"68","author":"FE Watt","year":"2016","unstructured":"Watt FE, et al. Acute molecular changes in synovial fluid following human knee injury: association with early clinical outcomes. Arthritis Rheumatol. 2016;68(9):2129\u201340.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"8360_CR51","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1002\/art.27755","volume":"62","author":"CH Tang","year":"2010","unstructured":"Tang CH, Hsu CJ, Fong YC. The CCL5\/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum. 2010;62(12):3615\u201324.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8360_CR52","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z","volume":"44","author":"N Alaaeddine","year":"2001","unstructured":"Alaaeddine N, et al. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum. 2001;44(7):1633\u201343.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8360_CR53","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.ocarto.2022.100240","volume":"4","author":"C Whitty","year":"2022","unstructured":"Whitty C, et al. Sustained delivery of the bone morphogenetic proteins BMP-2 and BMP-7 for cartilage repair and regeneration in osteoarthritis. Osteoarthritis Cartilage Open. 2022;4(1):100240.","journal-title":"Osteoarthritis Cartilage Open"},{"key":"8360_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.12659\/MSM.892160","volume":"21","author":"Y Liu","year":"2015","unstructured":"Liu Y, et al. Correlation of bone morphogenetic protein-2 levels in serum and synovial fluid with disease severity of knee osteoarthritis. Med Sci Monit. 2015;21:363\u201370.","journal-title":"Med Sci Monit"},{"issue":"1","key":"8360_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.joca.2017.08.015","volume":"26","author":"V Deshmukh","year":"2018","unstructured":"Deshmukh V, et al. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2018;26(1):18\u201327.","journal-title":"Osteoarthritis Cartilage"},{"key":"8360_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/1471-2474-11-257","volume":"11","author":"S Honsawek","year":"2010","unstructured":"Honsawek S, et al. Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC Musculoskelet Disord. 2010;11:257.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"8360_CR57","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/art.38799","volume":"66","author":"T Funck-Brentano","year":"2014","unstructured":"Funck-Brentano T, et al. Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice. Arthritis Rheumatol. 2014;66(11):3028\u201339.","journal-title":"Arthritis Rheumatol"},{"issue":"7\u20138","key":"8360_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.clinbiochem.2014.03.011","volume":"47","author":"T Mabey","year":"2014","unstructured":"Mabey T, et al. Plasma and synovial fluid sclerostin are inversely associated with radiographic severity of knee osteoarthritis. Clin Biochem. 2014;47(7\u20138):547\u201351.","journal-title":"Clin Biochem"},{"issue":"2","key":"8360_CR59","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00296-010-1733-6","volume":"32","author":"AR Upton","year":"2012","unstructured":"Upton AR, et al. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. Rheumatol Int. 2012;32(2):535\u201340.","journal-title":"Rheumatol Int"},{"issue":"9","key":"8360_CR60","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.clinbiochem.2008.02.011","volume":"41","author":"A Pilichou","year":"2008","unstructured":"Pilichou A, et al. High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem. 2008;41(9):746\u20139.","journal-title":"Clin Biochem"},{"issue":"12","key":"8360_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11926-019-0868-z","volume":"21","author":"C Xie","year":"2019","unstructured":"Xie C, Chen Q. Adipokines: new therapeutic target for osteoarthritis? Curr Rheumatol Rep. 2019;21(12):71.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"8360_CR62","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-14-0405","volume":"223","author":"J Friedman","year":"2014","unstructured":"Friedman J. 20 years of leptin: leptin at 20: an overview. J Endocrinol. 2014;223(1):T1-8.","journal-title":"J Endocrinol"},{"issue":"2","key":"8360_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/joca.2000.0366","volume":"9","author":"I Martin","year":"2001","unstructured":"Martin I, et al. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage. 2001;9(2):112\u20138.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"8360_CR64","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.joca.2015.06.014","volume":"23","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, et al. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis. Osteoarthritis Cartilage. 2015;23(12):2259\u201368.","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"8360_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1053\/berh.2001.0195","volume":"15","author":"J Martel-Pelletier","year":"2001","unstructured":"Martel-Pelletier J, Welsch DJ, Pelletier JP. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol. 2001;15(5):805\u201329.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8360_CR66","doi-asserted-by":"publisher","first-page":"116786","DOI":"10.1016\/j.lfs.2019.116786","volume":"234","author":"EE Mehana","year":"2019","unstructured":"Mehana EE, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review. Life Sci. 2019;234:116786.","journal-title":"Life Sci"},{"issue":"12","key":"8360_CR67","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1002\/jcb.23298","volume":"112","author":"P Verma","year":"2011","unstructured":"Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011;112(12):3507\u201314.","journal-title":"J Cell Biochem"},{"issue":"6","key":"8360_CR68","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/art.40820","volume":"71","author":"K Aso","year":"2019","unstructured":"Aso K, et al. Associations of symptomatic knee osteoarthritis with histopathologic features in subchondral bone. Arthritis Rheumatol. 2019;71(6):916\u201324.","journal-title":"Arthritis Rheumatol"},{"issue":"16","key":"8360_CR69","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","volume":"363","author":"NE Lane","year":"2010","unstructured":"Lane NE, et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med. 2010;363(16):1521\u201331.","journal-title":"N Engl J Med"},{"issue":"11","key":"8360_CR70","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","volume":"53","author":"Y Cho","year":"2021","unstructured":"Cho Y, et al. Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med. 2021;53(11):1689\u201396.","journal-title":"Exp Mol Med"},{"issue":"12","key":"8360_CR71","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O","volume":"41","author":"C Melchiorri","year":"1998","unstructured":"Melchiorri C, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998;41(12):2165\u201374.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8360_CR72","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.joca.2010.08.016","volume":"18","author":"O Stannus","year":"2010","unstructured":"Stannus O, et al. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage. 2010;18(11):1441\u20137.","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"8360_CR73","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2020.01.016","volume":"28","author":"MHJ van den Bosch","year":"2020","unstructured":"van den Bosch MHJ, van Lent P, van der Kraan PM. Identifying effector molecules, cells, and cytokines of innate immunity in OA. Osteoarthritis Cartilage. 2020;28(5):532\u201343.","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08360-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T10:57:27Z","timestamp":1723546647000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08360-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8360"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08360-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the National Medical Ethics Committee of Slovenia on 27 July, 2022. The approval number is 0120\u2013273\/2022\/3.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"533"}}